Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
1.
Hum Vaccin Immunother ; 11(3): 776-88, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25750999

RESUMO

The Neisseria meningitidis outer membrane protein PorA from a Chilean strain was purified as a recombinant protein. PorA mixed with AbISCO induced bactericidal antibodies against N. meningitidis in mice. When PorA was fused to the Helicobacter pylori HpaA antigen gene, the specific response against H. pylori protein increased. Splenocytes from PorA-immunized mice were stimulated with PorA, and an increase in the secretion of IL-4 was observed compared with that of IFN-γ. Moreover, in an immunoglobulin sub-typing analysis, a substantially higher IgG1 level was found compared with IgG2a levels, suggesting a Th2-type immune response. This study revealed a peculiar behavior of the purified recombinant PorA protein per se in the absence of AbISCO as an adjuvant. Therefore, the resistance of PorA to proteolytic enzymes, such as those in the gastrointestinal tract, was analyzed, because this is an important feature for an oral protein adjuvant. Finally, we found that PorA fused to the H. pylori HpaA antigen, when expressed in Lactococcus lactis and administered orally, could enhance the antibody response against the HpaA antigen approximately 3 fold. These observations strongly suggest that PorA behaves as an effective oral adjuvant.


Assuntos
Adesinas Bacterianas/imunologia , Adjuvantes Imunológicos/administração & dosagem , Anticorpos Antibacterianos/sangue , Helicobacter pylori/imunologia , Porinas/imunologia , Adesinas Bacterianas/administração & dosagem , Adesinas Bacterianas/genética , Adjuvantes Imunológicos/genética , Administração Oral , Animais , Feminino , Imunoglobulina G/sangue , Interferon gama/metabolismo , Interleucina-4/metabolismo , Lactococcus lactis/genética , Lactococcus lactis/metabolismo , Leucócitos Mononucleares/imunologia , Camundongos Endogâmicos BALB C , Porinas/administração & dosagem , Porinas/genética , Proteínas Recombinantes de Fusão/administração & dosagem , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/imunologia , Soro/química , Baço/imunologia
2.
Vigía (Santiago) ; 13(27): 59-63, 2012. tab, graf
Artigo em Espanhol | LILACS, MINSALCHILE | ID: lil-620955

RESUMO

La enfermedad meningocócica es de distribución mundial y presenta brotes de gran magnitud en el cinturón de la meningitis (África Subsahariana). A partir de 2001, la tendencia de la enfermedad en Chile disminuye, cambiando su presentación a baja endemia. Así, en el 2010 presentó una incidencia de 0,5 por cien mil habitantes. El grupo más afectado son los menores de 5 años, y de éstos, los menores de un año. Además, desde 1994 el serogrupo C fue considerado reemergente, produciendo brotes en 1999 y 2002. Esta enfermedad es de vigilancia universal e inmediata, cuyo sistema de vigilancia contempla indicadores de calidad, que evalúan los componentes clínico, epidemiológico y laboratorio. Este artículo analiza la situación epidemiológica de la enfermedad en Chile y su tendencia mundial, así como el fundamento para el cumplimiento de indicadores que requieren una respuesta oportuna frente al caso sospechoso sin esperar la confirmación de laboratorio.


Meningococcal disease has worldwide distribution and present large-scale outbreaks on the meningitis belt (sub-Saharian Africa). Since 2001, disease trend in Chile decreases, changing its presentation to low endemicity. Thus, 2010 registered an incidence of 0.5 per 100 thousand habitants. The most affected group was < 5 years old, specifically < 1 year old. Besides,since 1994, serogroup C was considered re-emergent, causing outbreaks in 1999 and 2002. This disease considersimmediate and universal surveillance and comprise quality indicators that assess clinical, epidemiological and laboratory components. This article analyze the epidemiological situation in Chile and its world trend, also the fundamental basis for indicator fullfilments that requires a fast response against a suspected case, without waiting for laboratory confirmation.


Assuntos
Humanos , Lactente , Pré-Escolar , Meningite Meningocócica/epidemiologia , Neisseria meningitidis , Notificação de Abuso , Monitoramento Epidemiológico , Chile
3.
Arch. chil. oftalmol ; 65(2): 11-17, 2010. graf
Artigo em Espanhol | LILACS | ID: lil-609871

RESUMO

Objetivo: Conocer y proveer de evidencia acerca de la sensibilidad de la flora bacteriana normal de la superficie ocular aislada en dos diferentes grupos sociales y etáreos de pacientes prontos a someterse a cirugía de Catarata y LASIK en nuestro país. Materiales y Métodos: Se cultivaron muestran conjuntivales de 221 pacientes previo a LASIK y de 180 pacientes de un grupo de Cataratas. De haber un cultivo positivo se realizó aislamiento e identificación bacteriana utilizando la técnica de difusión en disco de Kirby-Bauer para doce antibióticos. El análisis estadístico se hizo con chi-cuadrado y el test exacto de Fisher. Resultados: Hubo 66,8 por ciento de cultivos positivos, más frecuentemente gran positivos. SCN fue el aislado en mayor porcentaje (92,2 por ciento) y mostró una alta sensibilidad a Cloramfenicol, Tobramicina, Moxifloxacino y Gatifloxacino, intermedia para Levofloxacino, Gentamicina y Ciprofloxacino y menor para Eritromicina, Oxacilina, Cefalotina y Ceftriaxona (p<0,01). Todos los cultivos fueron sensibles a Vancomicina. No hubo diferencia estadísticamente significativa entre ambos grupos. Conclusiones: 1. Por primera vez nuestros resultados muestran que la flora y sensibilidad antibiótica son similares en pacientes a ser sometidos a LASIK y Catarata, siendo los SCN los más frecuentemente encontrados en ambos grupos de pacientes. 2. Las bacterias más comúnmente aisladas permanecen altamente sensibles a Cloramfenicol, Tobramicina, Moxifloxacino y Gatifloxacino.


Purpose: To know and provide a background on antibiotic susceptibility of normal ocular surface bacterial flora isolated from two different social and age groups of patients undergoing LASIK and cataract surgery in our country. Material and Methods: Conjunctival samples of 221 patients in a LASIK group and 180 patients in a cataract surgery group were cultivated. When there were a positive cultures, isolation and identification of the bacteria were made and antibiotic susceptibility tests were carried out, using the Kirby-Bauer disc diffusion technique for twelve antibiotics. Statistical analysis was performed using chi-square and exact Fisher test. Results: There were 66.8 percent of positive cultures, most of them gram positives. The most frequently isolated bacteria were the CNS (92,2 percent) that showed high sensitivity for Chloramphenicol, Tobramycin, Moxifloxacin and Gatifloxacin, intermedia for Levofloxacin, Gentamicin and Ciprofloxacin and lowest for Erytomycin, Oxacillin, Cefalotin and Ceftriaxone (p<0,01). All the cultures were susceptible to Vancomycin. There was not statistically difference between LASIK and cataract group. Conclusions: 1. For the first time, our results have shown that the conjunctival flora and its sensitivity to antibiotics are similar in the conjunctival flora of the patients undergoing LASIK surgery and Cataract, being CNS the bacterium most frequently found in both different groups of patients. 2. The most frequently isolated conjunctival bacteria remained highly sensitive to Chloramphenicol, Tobramycin, Moxifloxacin and Gatifloxacin.


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Antibacterianos/farmacologia , Bactérias/isolamento & purificação , Bactérias , Túnica Conjuntiva/microbiologia , Fatores Etários , Bactérias Gram-Positivas/isolamento & purificação , Bactérias Gram-Positivas , Distribuição de Qui-Quadrado , Catarata/microbiologia , Cloranfenicol/farmacologia , Farmacorresistência Bacteriana , Testes de Sensibilidade Microbiana , Cuidados Pré-Operatórios , Quinolinas/farmacologia , Fatores Socioeconômicos , Tobramicina/farmacologia
4.
Pediatr Infect Dis J ; 28(9): e265-70, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19710581

RESUMO

BACKGROUND: For the last 14 years the Pan American Health Organization has been promoting surveillance of invasive pneumococcal disease in Latin American children for better understanding of the disease tendencies regarding capsular types circulation in each country and susceptibility to antimicrobials. METHODS: Laboratory-based surveillance data from 10 Latin American countries collected from 2000 to 2005 were analyzed, including serotype distribution and susceptibility to beta-lactam antibiotics. RESULTS: Although 61 different capsular types were identified during the 6-year surveillance, 13 serotypes accounted for 86% of all isolates. These were consistently the most prevalent throughout the study period with serotype 14 predominating. Diminished susceptibility to penicillin was detected in 38% of all Streptococcus pneumoniae isolates, with the highest prevalence in Dominican Republic and Mexico. Decreased susceptibility to penicillin increased in Brazil and Colombia whereas decreased high resistance rates was recorded in Chile. CONCLUSIONS: These data indicate that 10 countries of the Region continue to have high quality laboratory-based surveillance for pneumococcal disease thus generating valuable information so that healthcare decision makers may prioritize interventions. The heptavalent vaccine will potentially cover from 52.4% to 76.5% of strains causing invasive pneumococcal disease and the 13 valent from 76.7% to 88.3%.


Assuntos
Infecções Pneumocócicas/epidemiologia , Infecções Pneumocócicas/microbiologia , Streptococcus pneumoniae/classificação , Streptococcus pneumoniae/isolamento & purificação , Antibacterianos/farmacologia , Técnicas de Tipagem Bacteriana , Pré-Escolar , Feminino , Humanos , Lactente , América Latina/epidemiologia , Masculino , Testes de Sensibilidade Microbiana , Resistência às Penicilinas , Vigilância da População/métodos , Prevalência , Sorotipagem , Streptococcus pneumoniae/efeitos dos fármacos , beta-Lactamas/farmacologia
5.
Rev Panam Salud Publica ; 25(4): 305-13, 2009 Apr.
Artigo em Espanhol | MEDLINE | ID: mdl-19531318

RESUMO

OBJECTIVE: To examine the development of resistance to erythromycin, chloramphenicol, trimethoprim-sulfamethoxazole (TMP-SMZ), and vancomycin of the invasive isolates of Streptococcus pneumoniae obtained from children in 10 Latin American/Caribbean countries during six years of surveillance. METHODS: Analysis of 8 993 isolates of S. pneumoniae recovered in 2000-2005 from children with invasive infections, who were less than 6 years of age, and from Argentina, Brazil, Chile, Colombia, Cuba, Dominican Republic, Mexico, Paraguay, Uruguay, or Venezuela. Antibiotic susceptibility was determined through the methods established and standardized by the SIREVA project. Multidrug resistance was defined as: resistance to three or more antibiotics of the same class; to the non-beta-lactams analyzed by this study; or, to the beta-lactams evaluated by a previous study, in which 37.8% of these isolates showed decreased susceptibility to penicillin. RESULTS: Some degree of resistance was found to TMP-SMZ and erythromycin (56.4% and 15.4% of the isolates studied, respectively), with 4.6% highly resistant to chloramphenicol. All isolates were susceptible to vancomycin. The highest prevalence of TMP-SMZ resistance was observed in the pneumonia isolates; and that of erythromycin, in cases of sepsis (61.6% and 25.5%, respectively; P < 0.01). The highest prevalence of TMP-SMZ resistance was found in Brazil (71.9%), and that of erythromycin, in Mexico (38.2%) and Venezuela (32.9%). The 14, 6B, 19F, and 23F serotypes were most often associated with resistance to the antibiotics in the study. CONCLUSIONS: High and increasing rates of isolates resistant to TMP-SMZ and erythromycin were observed, as well as a decreasing percentage of isolates resistant to chloramphenicol. These trends highlight differences among the countries studied.


Assuntos
Farmacorresistência Bacteriana , Streptococcus pneumoniae/efeitos dos fármacos , Humanos , América Latina , Testes de Sensibilidade Microbiana
6.
Rev Panam Salud Publica ; 25(4): 337-43, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19531322

RESUMO

OBJECTIVE: To determine genetic relatedness of clone Colombia(5) ST289 with invasive Streptococcus pneumoniae serotype 5 isolates recovered in nine Latin American countries. METHODS: Forty-four invasive S. pneumoniae serotype 5 isolates recovered from children under 5 years of age in Bolivia, Chile, Dominican Republic, Ecuador, Nicaragua, Panama, Paraguay, Peru, and Venezuela were studied. Pulsed-field gel electrophoresis patterns of DNA treated with SmaI restriction enzyme were classified using Tenover's criteria and analyzed with the Fingerprinting II program to determine their genetic relatedness with the Colombian clone. RESULTS: All isolates had a genetic similarity of 78.5% or more with the Colombian clone. Thirteen electrophoretic subtypes derived of pattern A were identified, and five of them (A5, A6, A8, A13, A27) comprised 61.4% of the isolates. CONCLUSIONS: Clone Colombia(5) ST289 is disseminated in Latin America. This is important because S. pneumoniae serotype 5 frequently causes invasive disease in the region and is associated with trimethoprim-sulfamethoxazole resistance.


Assuntos
Streptococcus pneumoniae/genética , Streptococcus pneumoniae/isolamento & purificação , Colômbia , Humanos , América Latina
7.
Enferm Infecc Microbiol Clin ; 27(4): 213-8, 2009 Apr.
Artigo em Espanhol | MEDLINE | ID: mdl-19361890

RESUMO

INTRODUCTION: The emergence of methicillin-resistant Staphylococcus aureus (MRSA) has become a major epidemiological problem worldwide. METHODS: We determined the degree of association between the genotype screening results obtained by pulse-field gel electrophoresis (PFGE) and polymerase chain reaction (PCR) for 7 hypervariable DNA regions associated with the mecA gene (HVR-mecA PCR), in the epidemiological analysis of 36 MRSA strains unrelated to nosocomial outbreaks, isolated from hospitalized patients at the County Hospital of Valdivia (Chile). RESULTS: The strains were classified into 15 pulse types (A-O) and 5 genotypes (6, 14, 15, 16, and 17) by PFGE and HVR-mecA PCR, respectively. Most of the strains were grouped in pulse types D, E and I, which presented 85.7% similarity. The most common genotypes were 14 (36.1%) and 15 (33.3%). Each genotype detected by HVR-mecA PCR was distributed in more than one pulse type. The degree of association between genotypic screening by PFGE or HVR-mecA PCR was determined by calculating Cramer's V statistic and the contingency coefficient. In both cases, a value near 1 (0.84 and 0.78, respectively) was obtained, indicating a high association between these genotypic screenings. Thus these are complementary, not exclusionary techniques that can be equally applied. CONCLUSIONS: PFGE is a standardized, high-technology molecular tool with considerable discriminatory power. HVR-mecA PCR is a fast, simple, accessible tool that has lower discriminatory power; nonetheless it can serve as an alternative method for epidemiological research in MRSA strains.


Assuntos
Proteínas de Bactérias/genética , Eletroforese em Gel de Campo Pulsado , Resistência a Meticilina/genética , Staphylococcus aureus Resistente à Meticilina/genética , Reação em Cadeia da Polimerase , Chile/epidemiologia , Infecção Hospitalar/epidemiologia , Infecção Hospitalar/microbiologia , DNA Bacteriano/genética , Genótipo , Staphylococcus aureus Resistente à Meticilina/classificação , Proteínas de Ligação às Penicilinas , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Especificidade da Espécie , Infecções Estafilocócicas/epidemiologia , Infecções Estafilocócicas/microbiologia
8.
Rev. panam. salud pública ; 25(4): 305-313, abr. 2009. graf, tab
Artigo em Espanhol | LILACS | ID: lil-515969

RESUMO

OBJETIVO. Determinar la evolución de la resistencia a la eritromicina, el cloranfenicol, el trimetoprim-sulfametozaxol (SXT) y la vancomicina de aislamientos invasores de Streptococcus pneumoniae obtenidos de niños de 10 países de América Latina y del Caribe en seis años de vigilancia. MÉTODOS. Se analizaron 8 993 aislamientos de S. pneumoniae recuperados entre 2000 y 2005 de niños menores de 6 años con infecciones invasoras, procedentes de Argentina, Brasil, Chile, Colombia, Cuba, México, Paraguay, República Dominicana, Uruguay y Venezuela. La sensibilidad a los antibióticos se determinó mediante los métodos establecidos y estandarizados en el proyecto SIREVA. La resistencia a múltiples antibióticos se definió como la resistencia a tres o más familias de antibióticos, de los no betalactámicos analizados en este estudio o de los betalactámicos evaluados en un estudio previo en el que 37,8% de estos aislamientos presentaron sensibilidad disminuida a la penicilina. RESULTADOS. Se encontró algún grado de resistencia al SXT y la eritromicina (56,4% y 15,4% de los aislamientos estudiados, respectivamente) y 4,6% presentó alta resistencia al cloranfenicol. Todos los aislamientos fueron sensibles a la vancomicina. Se observó la mayor frecuencia de resistencia al SXT en los aislamientos de neumonía y a la eritromicina en los casos de sepsis (61,6% y 25,5%, respectivamente; P < 0,01). La mayor frecuencia de resistencia al SXT se observó en Brasil (71,9%) y a la eritromicina en México (38,2%) y Venezuela (32,9%). Los serotipos 14, 6B, 19F y 23F fueron los que más frecuentemente se asociaron con la resistencia a los antibióticos estudiados. CONCLUSIONES. Se observó una elevada y creciente frecuencia de aislamientos resistentes al SXT y la eritromicina, y una disminución en la proporción de aislamientos resistentes al cloranfenicol. Estas tendencias mostraron diferencias entre los países estudiados.


OBJECTIVE. To examine the development of resistance to erythromycin, chloramphenicol, trimethoprim-sulfamethoxazole (TMP-SMZ), and vancomycin of the invasive isolates of Streptococcus pneumoniae obtained from children in 10 Latin American/Caribbean countries during six years of surveillance. METHODS. Analysis of 8 993 isolates of S. pneumoniae recovered in 2000­2005 from children with invasive infections, who were less than 6 years of age, and from Argentina, Brazil, Chile, Colombia, Cuba, Dominican Republic, Mexico, Paraguay, Uruguay, or Venezuela. Antibiotic susceptibility was determined through the methods established and standardized by the SIREVA project. Multidrug resistance was defined as: resistance to three or more antibiotics of the same class; to the non-beta-lactams analyzed by this study; or, to the beta-lactams evaluated by a previous study, in which 37.8% of these isolates showed decreased susceptibility to penicillin. RESULTS. Some degree of resistance was found to TMP-SMZ and erythromycin (56.4% and 15.4% of the isolates studied, respectively), with 4.6% highly resistant to chloramphenicol. All isolates were susceptible to vancomycin. The highest prevalence of TMP-SMZ resistance was observed in the pneumonia isolates; and that of erythromycin, in cases of sepsis (61.6% and 25.5%, respectively; P < 0.01). The highest prevalence of TMP-SMZ resistance was found in Brazil (71.9%), and that of erythromycin, in Mexico (38.2%) and Venezuela (32.9%). The 14, 6B, 19F, and 23F serotypes were most often associated with resistance to the antibiotics in the study. CONCLUSIONS. High and increasing rates of isolates resistant to TMP-SMZ and erythromycin were observed, as well as a decreasing percentage of isolates resistant to chloramphenicol. These trends highlight differences among the countries studied


Assuntos
Humanos , Farmacorresistência Bacteriana , Streptococcus pneumoniae/efeitos dos fármacos , América Latina , Testes de Sensibilidade Microbiana
9.
Rev. panam. salud pública ; 25(4): 337-343, abr. 2009. ilus, mapas, tab
Artigo em Inglês | LILACS | ID: lil-515973

RESUMO

OBJECTIVE: To determine genetic relatedness of clone Colombia5 ST289 with invasive Streptococcus pneumoniae serotype 5 isolates recovered in nine Latin American countries. METHODS: Forty-four invasive S. pneumoniae serotype 5 isolates recovered from children under 5 years of age in Bolivia, Chile, Dominican Republic, Ecuador, Nicaragua, Panama, Paraguay, Peru, and Venezuela were studied. Pulsed-field gel electrophoresis patterns of DNA treated with SmaI restriction enzyme were classified using Tenover's criteria and analyzed with the Fingerprinting II program to determine their genetic relatedness with the Colombian clone. RESULTS: All isolates had a genetic similarity of 78.5 percent or more with the Colombian clone. Thirteen electrophoretic subtypes derived of pattern A were identified, and five of them (A5, A6, A8, A13, A27) comprised 61.4 percent of the isolates. CONCLUSIONS: Clone Colombia5 ST289 is disseminated in Latin America. This is important because S. pneumoniae serotype 5 frequently causes invasive disease in the region and is associated with trimethoprim-sulfamethoxazole resistance.


OBJETIVO: Determinar la relación genética del clon Colombia5 ST289 con los aislamientos invasores de Streptococcus pneumoniae serotipo 5 provenientes de nueve países latinoamericanos. MÉTODOS: Se estudiaron 45 aislamientos invasores de Streptococcus pneumoniae serotipo 5 procedentes de niños menores de 5 años de Bolivia, Chile, Ecuador, Nicaragua, Panamá, Paraguay, Perú, República Dominicana y Venezuela. Los patrones en electroforesis en gel de campo pulsante del ADN tratado con la enzima de restricción SmaI se clasificaron mediante el criterio de Tenover y se analizaron con el programa Fingerprinting II para determinar su relación genética con el clon colombiano. RESULTADOS: Todos los aislamientos tuvieron una similitud genética de 78,5 por ciento o mayor con el clon colombiano. Se identificaron 13 subtipos electroforéticos derivados del patrón A y cinco de ellos (A5, A6, A8, A13 y A27) constituyeron 61,4 por ciento de los aislamientos. CONCLUSIONES: El clon Colombia5 ST289 está diseminado por América Latina. Esto es importante ya que S. pneumoniae serotipo 5 es causa frecuente de enfermedades invasoras en la Región y está asociado con la resistencia a trimetoprim-sulfametoxazol.


Assuntos
Humanos , Streptococcus pneumoniae/genética , Streptococcus pneumoniae/isolamento & purificação , Colômbia , América Latina
10.
Rev Panam Salud Publica ; 25(4),abr. 2009 graf, tab
Artigo | PAHO-IRIS | ID: phr-9863
12.
J Infect Dis ; 198(12): 1809-17, 2008 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-18959497

RESUMO

BACKGROUND: We monitored pediatric invasive pneumococcal disease (IPD) in Santiago, Chile, from 1994 to 2007. METHODS: Three related data sets were generated: (1) IPD cases requiring hospitalization, 1994--2007; (2) cases of bacteremia detected among febrile patients aged 0-35 months seen in emergency departments, 2000--2007; and (3) nasopharyngeal carriage of pneumococcal serotypes, determined from repetitive culturing, among 524 newborns followed up through age 23 months. RESULTS: Of 2369 IPD cases requiring hospitalization, 1878 (79.3%) occurred in those aged 0-59 months, and 1200 (50.7%) occurred in those aged 6-35 months. Among infants aged 0-5 months, meningitis and sepsis comprised 48.4% of all IPD cases (serotype 5 predominated); among those 6-35 months old, 522 (43.5%) of 1200 cases were bacteremic pneumonia (serotype 14 predominated). Serotype 1 peritonitis was common among 5-14-year-old girls. Meningitis and sepsis exhibited high case fatality rates (14%-29%) among all ages. Remarkably, 34 (28.8%) of 118 children with sepsis died, versus 1 fatality (0.4%) among 276 children hospitalized with bacteremia without a focus (P < .001, Fisher's exact test). Serotype 5 was significantly more common among hospitalized patients < 36 months of age, whereas serotype 18C was overrepresented among ambulatory patients. The annual incidence of serotype 14 was stable; those of serotypes 1 and 5 fluctuated markedly. Serotypes 14, 5, and 1 were overrepresented among invasive compared with nasopharyngeal isolates. CONCLUSIONS: Clinical syndromes of IPD and predominant serotypes vary with age.


Assuntos
Distribuição por Idade , Infecções Pneumocócicas/epidemiologia , Infecções Pneumocócicas/microbiologia , Vigilância da População , Streptococcus pneumoniae/classificação , Pré-Escolar , Chile/epidemiologia , Humanos , Lactente , Recém-Nascido , Infecções Pneumocócicas/imunologia , Vacinas Pneumocócicas/imunologia , Estações do Ano , Sorotipagem , Fatores de Tempo , Vacinas Conjugadas/imunologia
13.
Rev Med Chil ; 136(5): 606-12, 2008 May.
Artigo em Espanhol | MEDLINE | ID: mdl-18769808

RESUMO

BACKGROUND: Streptococcus agalactiae is the main causing organism of invasive infections such as sepsis and meningitis in the newborn. AIM: To perform a genotype characterization of Streptococcus agalactiae strains coming form invasive infections of newborns and colonized pregnant women. MATERIAL AND METHODS: A group of 58 strains not related epidemiologically isolated from colonized pregnant women and invasive infections in newborns, were studied. Pulsed field electrophoresis (PFGE) and polymerase chain reaction amplification of hylB and IS 1,548 genes, as possible virulence markers, were performed. RESULTS: Among the studied strains, 37 genetic subtypes were observed. There were nine groups of identical PFGE patterns. Three corresponded to serotype la and six to serotype III. An erythromycin and clindamycin resistant clone was identified in three colonized women and a newborn with sepsis, which were not epidemiologically related. The hylB gene was equally present in cases of neonatal meningitis or colonized pregnant women. CONCLUSIONS: There was a great degree of polymorphism among the studied strains. The ample presence of hylB gene and the absence of the insertion element IS1548 in the hylB gene in invasive and colonizing strains, indicates that both groups of strains are potentially pathogenic.


Assuntos
Genes Bacterianos/genética , Infecções Estreptocócicas/microbiologia , Streptococcus agalactiae/genética , Chile , Eletroforese em Gel de Campo Pulsado , Feminino , Humanos , Recém-Nascido , Meningites Bacterianas/microbiologia , Reação em Cadeia da Polimerase , Gravidez , Complicações Infecciosas na Gravidez/microbiologia , Sepse/microbiologia , Sorotipagem , Streptococcus agalactiae/classificação
14.
Rev. méd. Chile ; 136(5): 606-612, mayo 2008. ilus
Artigo em Espanhol | LILACS | ID: lil-490698

RESUMO

Streptococcus agalactiae is the main causing organism of invasive infections such as sepsis and meningitis in the newborn. Aim: To perform a genotype characterization of Streptococcus agalactiae strains coming form invasive infections of newborns and colonized pregnant women. Material and methods: A group of 58 strains not related epidemiologically isolated from colonized pregnant women and invasive infections in newborns, were studied. Pulsed field electrophoresis (PFGE) and polymerase chain reaction amplification of hylB and IS 1548 genes, as possible virulence markers, were performed. Results: Among the studied strains, 37 genetic subtypes were observed. There were nine groups of identical PFGE patterns. Three corresponded to serotype la and six to serotype III. An erythromycin and clindamycin resistant clone was identified in three colonized women and a newborn with sepsis, which were not epidemiologically related. The hylB gene was equally present in cases of neonatal meningitis or colonized pregnant women. Conclusions: There was a great degree of polymorphism among the studied strains. The ample presence of hylB gene and the absence of the insertion element IS1548 in the hylB gene in invasive and colonizing strains, indicates that both groups of strains are potentially pathogenic.


Assuntos
Feminino , Humanos , Recém-Nascido , Gravidez , Genes Bacterianos/genética , Infecções Estreptocócicas/microbiologia , Streptococcus agalactiae/genética , Chile , Eletroforese em Gel de Campo Pulsado , Meningites Bacterianas/microbiologia , Reação em Cadeia da Polimerase , Complicações Infecciosas na Gravidez/microbiologia , Sepse/microbiologia , Sorotipagem , Streptococcus agalactiae/classificação
15.
Rev Chilena Infectol ; 24(6): 446-52, 2007 Dec.
Artigo em Espanhol | MEDLINE | ID: mdl-18180818

RESUMO

This study assessed the performance of the national norm for laboratory surveillance of invasive Streptococcus pneumoniae in adults of the Metropolitan Region (Chile). Material and Methods. We reviewed all notifications of isolates from patients > 15 years of age received by the Institute of Public Health of Chile during the period 2000-2006, submitted by health care facilities of the study region. We also reviewed the original records of sterile fluid cultures, in 14 public adult hospitals. Results. We found documentation of 1429 invasive S. pneumoniae isolates recovered from adult patients, including 1095 reported and 334 not-reported isolates. A 33% under-reporting rate was estimated for the 14 hospitals where local laboratory records were inspected. Age and clinical diagnosis were omitted in 23% and 78% of the notifications, respectively. Among 303 isolates from patients > 65 years of age that were investigated with Quellung reaction, 235 (78%) had capsular serotypes represented in the 23-valent polysaccharide vaccine. Conclusions. The Ministry of Health of Chile announced implementation of 23-valent vaccine immunization program for the elderly. In the perspective of future evaluations of the impact of this intervention, the results of this study indicate the need of reinforcing adherence and improving the quality of notifications of invasive S. pneumoniae.


Assuntos
Laboratórios/normas , Infecções Pneumocócicas/microbiologia , Streptococcus pneumoniae/isolamento & purificação , Adolescente , Adulto , Idoso , Chile , Notificação de Doenças/normas , Notificação de Doenças/estatística & dados numéricos , Hospitais Públicos , Humanos , Incidência , Laboratórios/estatística & dados numéricos , Pessoa de Meia-Idade , Infecções Pneumocócicas/epidemiologia , Estudos Retrospectivos , Sorotipagem , População Urbana
16.
Sex Transm Dis ; 33(2): 87-95, 2006 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-16432479

RESUMO

OBJECTIVE: : The objective of this study was to ascertain the antimicrobial susceptibility of Neisseria gonorrhoeae isolates from 6 South American and 13 Caribbean countries participating in the Gonococcal Antimicrobial Surveillance Program (GASP) from 1990 to 1999. STUDY: : A GASP network of laboratories was launched in the Americas and the Caribbean during the 1990s. Standardized methods and interpretative criteria were established for the isolation of N. gonorrhoeae, strain identification, and determination, and quality control of antimicrobial susceptibility. RESULTS: : Two countries (Argentina and Uruguay) maintained continuous surveillance during the study period. Some countries gathered data periodically and several others were unable to initiate antimicrobial surveillance as a result of lack of resources. The percentage of penicillin-resistant N. gonorrhoeae isolated in the region over the decade varied considerably (1.0-11.9% carried chromosomal resistance and 17.9-38.8% produced beta-lactamase) with an overall trend to declining numbers of penicillin-resistant isolates. For tetracycline, 7.4% to 36.3% carried chromosomal resistance, whereas 12.0% to 27.4% carried plasmid-mediated resistance. There were no reports of ciprofloxacin-resistant isolates, although N. gonorrhoeae with decreased susceptibility to ciprofloxacin and azithromycin as well as spectinomycin-resistant isolates were identified in some countries.


Assuntos
Antibacterianos/farmacologia , Farmacorresistência Bacteriana , Gonorreia/prevenção & controle , Neisseria gonorrhoeae/efeitos dos fármacos , Região do Caribe/epidemiologia , Gonorreia/microbiologia , Humanos , Testes de Sensibilidade Microbiana , Neisseria gonorrhoeae/classificação , Neisseria gonorrhoeae/isolamento & purificação , Vigilância da População , Controle de Qualidade , América do Sul/epidemiologia
17.
Rev. chil. infectol ; Rev. chil. infectol;12(3): 169-72, 1995. tab
Artigo em Espanhol | LILACS | ID: lil-173436

RESUMO

El tratamiento antimicrobiano de las enfermedades por transmisión sexual debe ser combinado ya que coexiste más de un agente microbiano. Los nuevos macrólidos azálicos podrían ser activos frente a la mayoría de los agentes y resolver el problema con un solo antimicrobiano. Se estudiaron 100 cepas de neisseria gonorrhoeae, ciprofloxacino fue la droga más activa (CIM 90= 0,015 mcg/ml). El 20 por ciento de las cepas fueron productoras de betalactamasa. De los macrólidos azalicos azitomicina fue el más activo (CIM 90= 0,25 mcg/ml)


Assuntos
Humanos , Criança , Amoxicilina/farmacologia , Antibacterianos/farmacologia , Ciprofloxacina/farmacologia , Técnicas In Vitro , Neisseria gonorrhoeae/efeitos dos fármacos , Azitromicina/farmacologia , Ciprofloxacina/farmacologia , Claritromicina/farmacologia , Resistência Microbiana a Medicamentos , Quimioterapia Combinada/farmacologia , Eritromicina/farmacologia , Gonorreia/tratamento farmacológico , Testes de Sensibilidade Microbiana , Roxitromicina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA